期刊文献+

奥美拉唑肠溶胶囊处方工艺验证及稳定性考察 被引量:6

The study of prescription process certification and stability of Omeprazole Enteric Capsules
下载PDF
导出
摘要 目的验证奥美拉唑肠溶胶囊处方及稳定性考察。方法将优选处方工艺制备的奥美拉唑肠溶胶囊按照《中国药典》2015年版方法进行有关物质、含量、耐酸力、溶出度等进行测定,并进行稳定性考察。结果奥美拉唑肠溶胶囊中含量、有关物质、耐酸力、溶出度及稳定性试验均符合《中国药典》2015年版质量标准的要求,所制得的胶囊剂在人工胃液中保持良好的耐酸力,并且在人工肠液中可以迅速完全的溶出。结论此工艺有效地解决了奥美拉唑的稳定性问题,而且制备工艺合理,重现性好,准确度高,适合大规模生产。 Objective To screen the optimal prescription of Omeprazole Enteric Capsules and observe its stability. Methods Omeprazole Enteric Capsules synthesised with optimizing prescription were determined according to methods of China Pharmacopoeia(2015 edition)for related substances,assay,acid - resistance,dissolution and the stability was inves-tigated. Results Assay,related substance,acid - resistance,dissolution and stability test of Omeprazole Enteric Capsules all met with the quality standard in China Pharmacopoeia(2015 edition). The capsules had good acid - resistance and dis-solved fast and completely in artificial intestinal juice. Conclusion This process had solved the stability of omeprazole ef-fectively. The preparation process with good reproducibility and high accuracy was suitable for mass production.
出处 《药学研究》 CAS 2016年第7期404-407,共4页 Journal of Pharmaceutical Research
关键词 奥美拉唑 肠溶胶囊 处方工艺 稳定性 Omeprazole Enteric capsule Formulation process Stability
  • 相关文献

参考文献12

  • 1任晓琴,杜宏国,陈霞玲.质子泵抑制剂的研究进展[J].甘肃科技,2014,30(2):126-128. 被引量:5
  • 2李正元,李洪程,李风林,宋成刚.奥美拉唑肠溶微丸胶囊的制备及质量考察[J].药学研究,2015,34(2):91-94. 被引量:10
  • 3ANGIOLILLO D J , GIBSON C M , CHENG S , et al. Differentialeffects of omeprazole and pantoprazole on the pharmacodynamicsand pharmacokinetics of clopidogrel inhealthy subjects:randomized, placebo - controlled,crossovercomparison studies[J] . Clin Pharmacol Ther, 2 0 1 1 ,8 9 ( 1 ) : 6 5 -74.
  • 4SUNG J J,LUO D,WU J C,et al. Early clinical experienceof the safety and effectiveness of Hemospray in achievinghemostasis in patients with acute peptic ulcerbleeding[J] . Endoscopy,2011 ,43(4) :291 -295.
  • 5CHENG E,ZHANG X,HUO X ,t al. Omeprazole blockseotaxin - 3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD [J].Gut,2 0 1 3 , 6 2 ( 6 ) :824 -832.
  • 6TOMS - WHITTLE L M, JOHN L H, BUCKLEY D A.Drug - induced subacute cutaneous lupus erythematosusasociated with omeprazole[J]. Clin Exp Dermatol,2011,3 6 (3) :281 -283.
  • 7BOWEN C L , HEMBERGER M D, KEHLER J R, et al.Utility of dried blood spot sampling and storage for increasedstability of photosensitive compounds [J]. Bioanalysis, 0 1 0 , ( 11 ) : 1823 -1828.
  • 8FONT ANAP,BERDAGUEP, CASTELLI C,et al. Clinicalpredictors of dual aspirin and clopidogrel poor responsivenessin stable cardiovascular patients from the ADRIEstudy[J]. J Thromb Haemost,2010,8( 12) ;2614 -2623.
  • 9VYAS S, PATEL A, LADVA K D, et a . Development a dvalidation of a stability indicating method for the enantioselectiveestimation of omeprazole enantiomers in the enteric -coated formulations by high - performance liquid chromatogrnphy[J].J Pham Bioallied Sci,2011,3 (2) :310 -314.
  • 10黄海,朱莹,徐万魁,张璐.奥美拉唑肠溶胶囊有关物质检查方法研究[J].中国药事,2011,25(3):276-278. 被引量:4

二级参考文献16

共引文献16

同被引文献21

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部